phase II multi-institut trial low-dos N- phosphonacetyl -l-aspart high-dos short-term infus treatment adenocarcinoma pancrea southwest oncolog group studi adenocarcinoma pancrea lethal malign chemotherapi littl impact natur histori diseas pala vivo vitro twenty-seven patient intraven push dose pala hour infus regimen partial respons elig patient respons rate toxic sever toxic death patient grade toxic pala schedul effect adenocarcinoma pancrea 